Investors

What's New

Lupin Q1 FY2026 Results

Press Release

August 5, 2025

Lupin Receives US FDA Approvals for Liraglutide and Glucagon Injectable Products

Press Release

July 24, 2025

Lupin Achieves GMP Certification from TGA Australia for Dabhasa API Facility

Press Release

July 17, 2025

Lupin Launches Loteprednol Etabonate Ophthalmic Suspension, 0.5% in the United States

Press Release

July 16, 2025

Lupin and Zentiva Sign License and Supply Agreement for Commercializing Certolizumab

Press Release

July 9, 2025

Lupin Launches Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06% in the United States

Press Release

July 4, 2025

Lupin Receives Approval from U.S. FDA for Loteprednol Etabonate Ophthalmic Gel

Press Release

July 1, 2025

Lupin Carves Out LupinLife Consumer Healthcare

Press Release

July 1, 2025

Lupin Launches Prucalopride Tablets in the United States

Press Release

June 25, 2025

Lupin Receives Approval from U.S. FDA for Prucalopride Tablets

Press Release

June 25, 2025

Lupin and Sino Universal Pharmaceuticals Sign License and Supply Agreement for Tiotropium DPI in China

Press Release

June 16, 2025

Lupin Foundation Flags off Mobile Medical Van in Palghar to Strengthen Non-Communicable Disease Care

Press Release

June 9, 2025

Lupin Receives Tentative Approval from U.S. FDA for Oxcarbazepine ER Tablets

Press Release

June 7, 2025

Lupin Announces Presentation of Phase 1 Data on LNP7457 (PRMT5 inhibitor) at the American Society of Clinical Oncology – Annual Meeting 2025

Press Release

May 26, 2025

Lupin and Honeywell Move Forward Jointly with Plans for HFO Technology in Inhalers

Press Release

May 20, 2025

Punita Lal Joins Lupin Board as Additional Director

Press Release

May 15, 2025

Lupin FY2025 Results

Press Release

May 14, 2025

Lupin Launches Tolvaptan Tablets in the U.S. with 180-Day Exclusivity

Press Release

May 13, 2025

Lupin Receives Approval from U.S. FDA for Raltegravir Tablets USP, 600 mg

Press Release

May 8, 2025

Lupin Receives Approval from U.S. FDA for Raltegravir Tablets USP, 600 mg

Press Release

May 8, 2025

Lupin Launches Eslicarbazepine Acetate Tablets in the United States

Press Release

May 7, 2025

Lupin Receives Approval from U.S. FDA for Tolvaptan Tablets

Press Release

April 24, 2025

Reports & Filings

Integrated Report 2025

Download Now View all

Q1 FY26

Gross Profit : INR 43,919 Mn
Gross profit margin : 71.3%
Investment in R&D : INR 4,844 Mn

Download Results View all Results

Exchange filings (BSE/NSE)

View all

Corporate Governance

Committees of the Board

Code of Conduct

Policies

Shareholder Information

News and Events

Press Release

Lupin Q1 FY2026 Results

Explore

Annual General Meeting

The 42^nd Annual General Meeting was held on Thursday, August 2, 2024.

Explore

Investor Contacts

Shareholder Services

investorservices@lupin.com
rnt.helpdesk@in.mpms.mufg.com
Investor Relations

ravikagrawal@lupin.com

Cookie	Duration	Description
ARRAffinity	6 months	This cookie is set by websites that run on Windows Azure cloud platform. The cookie is used to affinitize a client to an instance of an Azure Web App.
ASP.NET_SessionId		This cookie is used in sites developed with Microsoft.Net. When a user start browsing a unique session ID is created, which keeps track of all the information regarding that session.This information is stored in the web server and it is identified via a GUID.The GUID is essential for any ASP.NET site to function properly.
cookielawinfo-checkbox-advertisement	6 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertisement".
cookielawinfo-checkbox-analytics	6 months	These cookies are set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-functional	6 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	6 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	6 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Other".
cookielawinfo-checkbox-performance	6 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	6 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Cookie	Duration	Description
_ga	1 years	This cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors.
_gat_gtag_UA_139647988_1	1 minute	These cookies are set by Google Analytics which is a simple tool that helps us measure how users interact with our website. As a user navigates between web pages, Google Analytics records information about the page a user has visited, for example the URL of the page. The cookies themselves are used to 'remember' what a user has done on previous pages and interactions with our website.
_gid	1 day	This cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.

Cookie	Duration	Description
_fbp	3 months	_fbp. Used by Facebook to deliver advertising. The cookie contains an encrypted Facebook user ID and browser ID. It will receive information from this website to better target and optimise advertising.
IDE	1 year	Used by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
test_cookie	15 minutes	This cookie is set by doubleclick.net. The purpose of the cookie is to determine if the user's browser supports cookies.
VISITOR_INFO1_LIVE	5 months 27 days	This cookie is set by Youtube. Used to track the information of the embedded YouTube videos on a website.

Cookie	Duration	Description
ARRAffinitySameSite	session	No description
CONSENT	6 months	No description

Investors

What's New

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Reports & Filings

Integrated Report 2025

Q1 FY26

Exchange filings (BSE/NSE)

Corporate Governance

Shareholder Information

News and Events

Press Release

Annual General Meeting

Investor Contacts

Shareholder Services

Investor Relations

Subscribe for Investor updates